DAFNA Capital Management LLC

Position in STOK — Stoke Therapeutics, Inc.

CIK 1389933 LOS ANGELES, CA

Position in STOK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,282,230

+$20,940 QoQ

Shares Held

130,875

0.0% QoQ

Ownership

0.203%

of shares outstanding

% of Portfolio

0.87%

of 13F equity value

Holder Rank

#49

of 198 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. STOK ranks #16 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	562,630	$105,369,346
2	NKTR	Nektar Therapeutics	318,380	$22,226,107
3	DNLI	Denali Therapeutics Inc.	739,014	$19,007,440
4	IDYA	IDEAYA Biosciences, Inc.	497,240	$18,532,134
5	XENE	Xenon Pharmaceuticals Inc.	250,772	$15,136,597
6	CYTK	Cytokinetics Inc	171,998	$14,652,509
7	RCUS	Arcus Biosciences, Inc.	441,829	$13,621,588
8	ASND	Ascendis Pharma A/S	48,469	$12,927,651

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,282,230	130,875	0.0%	Shares	Sole	2026-08-14
2026-03-31	$4,261,290	130,875	+20.2%	Shares	Sole	2026-05-15
2025-12-31	$3,455,692	108,875	-35.9%	Shares	Sole	2026-02-17
2025-09-30	$3,990,088	169,791	-66.2%	Shares	Sole	2025-11-14
2025-06-30	$5,697,382	501,972	+13.1%	Shares	Sole	2025-08-14
2025-03-31	$2,952,586	443,998	+159.5%	Shares	Sole	2025-05-15
2024-12-31	$1,887,199	171,097	-17.5%	Shares	Sole	2025-02-14
2024-09-30	$2,549,277	207,427	0.0%	Shares	Sole	2024-11-14
2024-06-30	$2,802,338	207,427	+43.1%	Shares	Sole	2024-08-14
2024-03-31	$1,957,500	145,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.